↓ Skip to main content

Dove Medical Press

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future

Overview of attention for article published in Neuropsychiatric Disease and Treatment, September 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
148 Mendeley
Title
A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
Published in
Neuropsychiatric Disease and Treatment, September 2019
DOI 10.2147/ndt.s209284
Pubmed ID
Authors

Leslie Citrome, Joseph P McEvoy, Mark S Todtenkopf, David McDonnell, Peter J Weiden

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 148 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 148 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 20 14%
Student > Master 17 11%
Other 8 5%
Researcher 7 5%
Student > Postgraduate 7 5%
Other 21 14%
Unknown 68 46%
Readers by discipline Count As %
Medicine and Dentistry 12 8%
Pharmacology, Toxicology and Pharmaceutical Science 10 7%
Nursing and Health Professions 9 6%
Neuroscience 9 6%
Biochemistry, Genetics and Molecular Biology 8 5%
Other 24 16%
Unknown 76 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2023.
All research outputs
#2,576,903
of 25,385,509 outputs
Outputs from Neuropsychiatric Disease and Treatment
#331
of 3,131 outputs
Outputs of similar age
#51,716
of 350,007 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#9
of 89 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,131 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,007 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.